NIB Holdings Ltd · ASX:NHF

NIB — Investor Day (June 2013)

51 slides from NIB's investor day presentation, Jun 14, 2013

  1. Slide 1: ASX announcement: 2013 nib strategy briefing

    nib holdings limited t 13 14 63 Head Office f 02 4925 1999 22 Honeysuckle Drive Newcastle NSW 2300 e nib@nib.com.au abn 51 125 633 856 w nib.com.au 14 June 2013 The Manager Company Announcements Australian Securities Exchange Limited Level 4, Bridge Street SYDNEY NSW 2000 Subject: 2013 nib strategy

  2. Slide 2: 2013 Strategy Briefing

    2013 Strategy Briefing Friday 14 June 2013 1

  3. Slide 3: Welcome & Strategic Update

    Welcome & Strategic Update Mark Fitzgibbon Chief Executive Officer & Managing Director 2

  4. Slide 4: Agenda

    Agenda Time Topic Presenter 9.00am Business Strategy update Mark Fitzgibbon - CEO & Managing Director 10.00am Finance Michelle McPherson - Chief Financial Officer 10.30am Morning tea arhi Organic growth Rhod McKensey - Group Manager, arhi 10.45 am Our own efforts and role of intermediaries James Bar

  5. Slide 5: Strategic Plan

    Strategic Plan OUR VISION nib is a leading financier of the nation’s healthcare spending with a reputation for innovative products, value for money, outstanding customer service, corporate social responsibility and strong shareholder returns. OUR MISSION To help people afford healthcare when and whe

  6. Slide 6: Industry trends

    Industry trends  We’re spending more and more on our healthcare.  Government’s relative funding contribution cannot be sustained.  Inevitably, the private sector will play an increased role.  International cross border health care is accelerating. 5

  7. Slide 7: Business Strategy

    Business Strategy Grow our Australian residents health insurance business organically at circa 10% annual premium growth (4-5% 1 policyholder growth) through building national brand presence and with an emphasis on <40 market (Virgin Green), >55 market (Virgin Silver), other tactical niche opportuni

  8. Slide 8: nib Group Structure

    nib Group Structure Mark Fitzgibbon Managing Director & CEO Vacant Justin Vaughan Brendan Mills Rhod McKensey Michelle McPherson Group Manager Group Manager Rob Hennin Chief Information Group Manager Chief Financial Officer International & New Benefits & Provider nib New Zealand CEO Officer arhi / D

  9. Slide 9: Possible change of Federal Government implications

    Possible change of Federal Government implications  Recent legislative changes remain in place (income testing and indexation of the Australian Government Rebate and removal of Australian Government Rebate from LHC loading).  Sale of Medibank Private  Expanded role for PHI? Denticare?  Possible

  10. Slide 10: Finance Update

    Finance Update Michelle McPherson Chief Financial Officer 10

  11. Slide 11: Financial targets & guidance – FY13

    Financial targets & guidance – FY13  Group insurance premium revenue for FY13 of $1.2b - $1.3b.  Forecast FY13 consolidated pre-tax net underwriting profit excluding non- cash amortisation of intangible assets on acquisitions (TMIL and IMAN) is expected to be at the low end of $75m - $78m guidance

  12. Slide 12: Financial targets & guidance – FY13

    Financial targets & guidance – FY13  FY13 nib New Zealand net underwriting profit excluding non-cash amortisation of intangible assets on acquisition is expected to be in the range of $5m - $7m. Acquisition of TOWER will be EPS accretive in FY13 (excluding acquisition costs and non-cash amortisatio

  13. Slide 13: Capital management & dividend

    Capital management & dividend  As at 31 March 2013 nib had $33.1m in available capital above internal prudential requirements.  FY13 final dividend will be in range of 60-70% FY13 NPAT.  New Capital Standards not anticipated to have a material impact on our capital requirements.  PHIAC issued Ro

  14. Slide 14: arhi Organic Growth

    arhi Organic Growth Rhod McKensey Group Manager Australian Residents Health Insurance James Barr Group Manager Marketing & Products 15

  15. Slide 15: Agenda

    Agenda  Industry Growth and Outlook  Regulatory Changes  Tactics  New Product Range  New Customer Acquisition  Customer Retention  Focus for the next 12 months 16

  16. Slide 16: Industry growth & outlook

    Industry growth & outlook Annual Policyholder Growth - 12 months to 31 March 14.0% nib Industry 12.1% 12.0% 10.0% 8.0% 6.0% 5.6% 5.6% 5.6% 5.6% 4.9% 5.0% 4.0% 3.6% 3.4% 3.4% 3.1% 2.7% 2.0% 0.0% Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Source: PHIAC and company data  Despite recent regulatory chang

  17. Slide 17: Regulatory changes & impact

    Regulatory changes & impact Medicare Levy Surcharge – changes to income thresholds (2010) 1 - People without PHI pay an extra 1% to 1.5% in tax if their income exceeds certain thresholds and don’t have appropriate hospital cover. Government aligned income thresholds with annual increases in average

  18. Slide 18: Tactics

    Tactics  Continue to grow organically through building brand awareness in the key states of NSW, QLD, VIC and WA targeting the  Under 40’s new to category market segment;  Over 55’s market segment.  Focus on value based selling to further increase policy “buy up”.  Maintain marketing and retail

  19. Slide 19: Channel strategy

    Channel strategy Sales Channel Mix by Financial Year 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% FY08 FY09 Call Centre Corporate FY10 Other Retail FY11 Retail Brokers Web FY12 FY13 YTD Source: Company data  The retail broker channel continues to grow and will account for around 30% of sales in FY13

  20. Slide 20: Retail brokers

    Retail brokers  Retail brokers expected to account for ~30% of all policyholder sales in FY13.  Why we use aggregators  Continuing consumer trend to use aggregators  Only pay for sales we get (low risk investment)  Profitable  Scalable (in terms of investment and sales)  Access to niche segme

  21. Slide 21: New customer acquisition

    New customer acquisition 35% Effective Commission - 6 Mths Rolling $600 30% $500 25% $400 20% $300 15% $200 10% $100 5% $0 0% Jul-201 0 Jul-201 1 Jul-201 2 Feb-20 10 Mar-20 10 Jun-20 10 Jan-20 11 Feb-20 11 Mar-20 11 Jun-20 11 Jan-20 12 Feb-20 12 Mar-20 12 Jun-20 12 Jan-20 13 Feb-20 13 Mar-20 13 Apr

  22. Slide 22: New product range – average premium

    New product range – average premium Monthly Sales Average Premium Income (API) $2,500 $2,400 $2,300 Annual API $2,200 $2,100 $2,000 $1,900 New product launch $1,800 $1,700 $1,600 $1,500 Source: Company data  During March 2013 nib launched a new product range which allows customers to better tailor

  23. Slide 23: New product range – Over 55s

    New product range – Over 55s 55+ Proportion of Total Sales 25.0% 20.0% 15.0% New product launch 10.0% 5.0% 0.0% Source: Company data  The new products have proven to be a “hit” with the over 55s segment.  The proportion of sales to over 55s has increased significantly. This change is consistent ac

  24. Slide 24: Retention

    Retention Average industry retention index* 0.94 0.92 0.90 0.88 0.86 0.84 Restricted Insurers Open Insurers 0.82 nib 0.80 2007-08 2008-09 2009-10 2010-11 2011-12 Source: PHIO and company data  nib’s lapse increase line with the launch of our Virgin Green Strategy in FY07. nib’s lapse experience. in

  25. Slide 25: Retention – Net Promoter Score

    Retention 30% Net Promoter Score 25% 20% 15% 10% 5% 0% Source: Company data  We have worked to create a customer-focused culture.  Introduced the Net Promoter Score* in July 2010 (survey sent to customers following contact with nib).  Despite some testing times we’ve made solid progress. * NPS qu

  26. Slide 26: Customer survival rate

    Retention Retention Rate by Net Promoter Score 100.0% 10 95.0% 9 8 Customer survival rate 90.0% 7 6 85.0% 5 4 80.0% 3 2 75.0% 1 0 70.0% No Response 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Months since NPS received Source: Company data  NPS correlates with a customer’s reten

  27. Slide 27: Specific retention actions

    Retention Specific retention actions  New product suite designed to provide customers with greater value for money by providing more choice and tailored products to better suit their needs.  Develop a more effective save and win back process via dedicated call centre retention team.  Outbound cal

  28. Slide 28: Focus for the next 12 months

    Focus for the next 12 months Brand  Continue to invest in sponsorships and media to maintain/build a strong brand in four key states. Focus on 20-39 (Virgin Green) and 55 Plus (Virgin Silver) segments. Distribution  Web – Grow the channel through continued investment. Ensure we stay ‘ahead of the

  29. Slide 29: arhi Claims Management & Premium Pricing

    arhi Claims Management & Premium Pricing Rhod McKensey Group Manager Australian Residents Health Insurance Gavin Ward Business Intelligence Manager 31

  30. Slide 30: Claims overview

    Claims overview  Overall inflation is tracking slightly higher than expectations.  For the 12 months to 31 March 2013 per person hospital (including medical, prostheses and risk equalisation) costs have increased by 4.6% (4.4% pre risk equalisation), in line with the industry average of 4.3%. Our

  31. Slide 31: Hospital claims

    Hospital claims Inflation (12 months to 31 Mar-13) Annual $m Total Drawing rate per person Setting/service nib nib Industry nib Industry Private 317.8 10.1% 6.8% 4.5% 3.7% Public 58.0 12.5% 16.6% 6.8% 13.6% Day 17.3 20.2% 8.7% 14.1% 5.5% Prostheses 76.0 7.4% 5.6% 1.9% 2.5% Medical 72.7 8.0% 6.9% 2.5

  32. Slide 32: Ancillary claims

    Ancillary claims Inflation (12 months to 31 Mar-13) Annual $m Total Drawing rate per person % of costs* Service nib nib Industry nib Industry nib Industry Dental 132.0 11.1% 9.6% 5.2% 5.0% 56% 52% Optical 45.4 7.6% 8.3% 1.9% 3.8% 56% 55% Physiotherapy 23.5 11.0% 11.5% 5.0% 6.8% 60% 51% Chiropractic

  33. Slide 33: Claims strategy & outlook

    Claims strategy & outlook  New Group Manager Benefits will be heavily involved in benefit design, claims analysis, consumer empowerment, disease prevention/management and hospital/provider contracting across the entire nib Group (Australia, New Zealand, workers, students, nib Options).  Key focus

  34. Slide 34: Pricing

    Pricing The 2013 premium approval process was different to previous years:  PHIAC took the lead role in the assessment of submissions – previously it was led by the Department of Health & Ageing. The information required in the submission was similar to previous years.  This year’s process was mor

  35. Slide 35: nib New Zealand

    nib New Zealand Update on TOWER New Zealand acquisition Rob Hennin Chief Executive Officer nib New Zealand 38

  36. Slide 36: nib New Zealand Business Strategy

    nib New Zealand Business Strategy Business Strategy Position and develop our new business in New Zealand as a challenger and grow the market and our share. Tactics  Get the business ready:  Right people on the bus, transition work, system enhancements, process improvements  Direct to consumer off

  37. Slide 37: Transition progress

    Transition progress  nib acquired Tower Medical Insurance Limited in November 2012 for ~AU$81.3m (including approximately AU$7.9m in surplus capital).  New Structure  Board of Directors  Appointment of Alan Clarke as Chairman.  Board Members also include nib Group MD/CEO as well as 3 NEDs from

  38. Slide 38: nib New Zealand structure

    nib New Zealand structure Chief Executive Officer Rob Hennin Finance & Corporate Services Operations Distribution Product & Marketing Nick Corey David White Rachael Savage Kathy Crispin (effective 1 July 2013) 41

  39. Slide 39: New Zealand market

    New Zealand market Australia New Zealand A$1,499.5bn A$175.4bn (NZ$209.3nb) GDP 10.8% growth over four years1 7.5% growth over four years Population 22.8mm 4.4mm Number of insured people 10.76mm (46.9%) 1.34mm (30.2%) Inflation 2.5% 0.9% Unemployment 5.5% 6.2% Health spend (% of GDP) 9.3% 10.5% Heal

  40. Slide 40: New Zealand health care system

    New Zealand health care system  New Zealand residents may have access to a Government funded or subsidized healthcare system which provides primary, secondary and emergency health services.  The public health system (“PHS”) provides health services through public hospitals and public sector genera

  41. Slide 41: Industry players & distribution

    Industry players & distribution Insurer Market share Premiums (NZ$mm)² Structure  Friendly Society 65.6% 722.7  Also provides travel and student insurance  Owns Private Hospitals 13.5% 148.5  nib acquired TOWER Medical in December 2012  Subsidiary of Commonwealth Bank 7.6% 83.7  Health insuran

  42. Slide 42: Strategic milestones

    Strategic milestones Months (2012 – 2013) Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sept Oct Phase 1 Phase 2 Phase 3 Phase 4 Phase 1 (Nov – Dec 2012) Phase 3 (Feb – Oct 2013)  Complete acquisition of TOWER Medical  Begin synergy realisation, system enhancements and  Appoint interim management team

  43. Slide 43: What we like and don’t like

    What we like and don’t like What we like  Flexibility in product pricing and design  Opportunity to increase penetration and grow market share  Low competitor investment in brand, product innovation and online capability  Opportunity to better manage claims  Engaged workforce  Lack of competit

  44. Slide 44: New Ventures – International

    New Ventures – International Mark Fitzgibbon Chief Executive Officer & Managing Director Rebecca Urane Manager nib Options 48

  45. Slide 45: International Workers Health Insurance

    International Workers Health Insurance  As at 30 April 2013 approximately 110,000 457 visa holders in Australia.  FY12 industry GWP of $170m (excluding General Insurers), major PHI competitors include Medibank, BUPA and Australian Unity.  FY13 forecast:  High single digit net policyholder growth

  46. Slide 46: International Students Health Insurance

    International Students Health Insurance  Expected to break even in FY13.  Forecast approximately 9,000 polices by 30 June 2013 (3,328 policies 30 June 2012). Cultural Missions &  As at 31 March 2013, approximately Embassies 332,000 student visa holders in Australia.  FY12 GWP for industry estima

  47. Slide 47: nib options – the opportunity

    nib options– the opportunity Market for cosmetic treatment and medical travel is undeveloped Opportunity for a Accelerating company with mobility of people brand, expertise searching for care and resources to and choice corporatise Burgeoning demand for nib Model can be replicated healthcare Options

  48. Slide 48: nib options – Business Strategy

    nib options – Business Strategy Leverage nib’s brand reputation and distribution to support and grow the market for cosmetic, dental and surgical treatment both overseas and here in Australia. Invest strongly in products, marketing and sales capability based upon a philosophy that we are helping peo

  49. Slide 49: nib options – Business Model

    nib options – Business Model nib Options • Markets and advertises products and packages both in Australia and overseas • Directs sales enquiries and service Pacific Smiles Group Realsurgeons Realself (PSG) • Contracts with surgeons, facilities and other relevant Continues to market Receive dental cl

  50. Slide 50: nib options – Financial Assumptions

    nib options – Financial Assumptions  It’s estimated it will take 6 months to launch nib Options with a targeted “go live” date of November 2013.  Forecasting 1,000+ sales in Australia in FY14 (with 15% growth year on year).  Forecasting 1,000+ sales overseas in FY14 (with 20% growth year on year)

  51. Slide 51: 2013 Strategy Briefing

    2013 Strategy Briefing Friday 14 June 2013 56

nib holdings — Investor Day (June 2013) on 6ix